Genetic Disorders and the Fetus. Группа авторов
Shi‐hao Y. Prolaktin u amnijskoj tekucini i serumu u ranoj trudnoci. [Prolactin in amnionic fluid and serum of women in early pregnancy (author's transl.)]. Jugosl Ginekol Opstet 1981; 21:116.
441 441. Lee SE, Romero R, Park IS, et al. Amniotic fluid prostaglandin concentrations increase before the onset of spontaneous labor at term. J Matern Fetal Neonatal Med 2008; 21:89.
442 442. van de Beek C, Thijssen JH, Cohen‐Kettenis PT, et al. Relationships between sex hormones assessed in amniotic fluid, and maternal and umbilical cord serum: what is the best source of information to investigate the effects of fetal hormonal exposure? Horm Behav 2004; 46:663.
443 443. Cooper E, Anderson A, Bennett MJ, et al. Radioimmunoassay of thyroxine and 3,3′,5′‐triiodothyronine (reverse T3) in human amniotic fluid. Clin Chim Acta 1982; 118:57.
444 444. Vascotto C, Salzano AM, D'Ambrosio C, et al. Oxidized transthyretin in amniotic fluid as an early marker of preeclampsia. J Proteome Res 2007; 6:160.
445 445. Wu CH, Mennuti MT, Mikhail G. Free and protein‐bound steroids in amniotic fluid of midpregnancy. Am J Obstet Gynecol 1979; 133:666.
446 446. Merger C, Blanc B, Ruf H, et al. Dosage de la testosterone, delta 4‐androstenedione et S‐DHA dans le liquide amniotique et sexe foetal [The level of testosterone, delta 4‐androstenedione, and S‐DHA in liquor and fetal sex (author's transl.)]. J Gynecol Obstet Biol Reprod (Paris) 1981; 10:567.
447 447. Carson DJ, Okuno A, Lee PA, et al. Amniotic fluid steroid levels. Fetuses with adrenal hyperplasia, 46,XXY fetuses, and normal fetuses. Am J Dis Child 1982; 136:218.
448 448. Mean F, Pescia G, Vajda D, et al. Amniotic fluid testosterone in prenatal sex determination. J Genet Hum 1981; 29:441.
449 449. Robinson JD, Judd HL, Young PE, et al. Amniotic fluid androgens and estrogens in midgestation. J Clin Endocrinol Metab 1977; 45:755.
450 450. Abramovich DR, Herriot R, Stott J. Dihydrotestosterone levels at midpregnancy and term: a comparison with testosterone concentrations. Br J Obstet Gynaecol 1983; 90:232.
451 451. Perera DM, McGarrigle HH, Lawrence DM, et al. Amniotic fluid testosterone and testosterone glucuronide levels in the determination of foetal sex. J Steroid Biochem 1987; 26:273.
452 452. Roig MD, Sabria J, Valls C, et al. The use of biochemical markers in prenatal diagnosis of intrauterine growth retardation: insulin‐like growth factor I, Leptin, and alpha‐fetoprotein. Eur J Obstet Gynecol Reprod Biol 2005; 120:27.
453 453. Anand‐Ivell R, Ivell R, Driscoll D, et al. Insulin‐like factor 3 levels in amniotic fluid of human male fetuses. Hum Reprod 2008; 23:1180.
454 454. Blankstein J, Kraiem Z, Mashiah S, et al. Effect of dexamethasone administration at midgestation on cortisol levels in amniotic fluid. Isr J Med Sci 1979; 15:945.
455 455. Friedrich E, Habedank M, Cooreman G, et al. Diagnostik der fotalen Schilddrusenfunktion durch Amniocentese [Diagnostic possibilities of the function of the fetal thyroid gland by amniocentesis (author's transl.)]. Z Geburtshilfe Perinatol 1981; 185:96.
456 456. Perelman AH, Johnson RL, Clemons RD, et al. Intrauterine diagnosis and treatment of fetal goitrous hypothyroidism. J Clin Endocrinol Metab 1990; 71:618.
457 457. Stoll C, Willard D, Czernichow P, et al. Prenatal diagnosis of primary pituitary dysgenesis. Lancet 1978; i:932.
458 458. Buscher U, Hertwig K, Dudenhausen JW. Nachweis von Erythropoietin im Fruchtwasser [Detection of erythropoietin in amniotic fluid]. Geburtshilfe Frauenheilkd 1996; 56:243.
459 459. Kakuya F, Shirai M, Takase M, et al. Relationship between erythropoietin levels both in cord serum and amniotic fluid at birth and abnormal fetal heart rate records. Pediatr Int 2002; 44:414.
460 460. Teramo KA, Widness JA. Increased fetal plasma and amniotic fluid erythropoietin concentrations: markers of intrauterine hypoxia. Neonatology 2009; 95:105.
461 461. Mikovic Z, Mandic V, Parovic V, et al. Erythropoietin in amniotic fluid as a potential marker in distinction between growth restricted and constitutionally small fetuses. J Matern Fetal Neonatal Med 2014; 27:1134.
462 462. Basbug M, Serin IS, Ozcelik B, et al. Correlation of elevated leptin levels in amniotic fluid and maternal serum in neural tube defects. Obstet Gynecol 2003; 101:523.
463 463. Bala RM, Wright C, Bardai A, et al. Somatomedin bioactivity in serum and amniotic fluid during pregnancy. J Clin Endocrinol Metab 1978; 46:649.
464 464. Gautray JP, Jolivet A, Vielh JP, et al. Presence of immunoassayable beta‐endorphin in human amniotic fluid: elevation in cases of fetal distress. Am J Obstet Gynecol 1977; 129:211.
465 465. Hankins GD, Rowe J, Quirk JG, Jr., et al. Significance of brown and/or green amniotic fluid at the time of second trimester genetic amniocentesis. Obstet Gynecol 1984; 64:353.
466 466. Szeto HH, Zervoudakis IA, Cederqvist LL, et al. Amniotic fluid transfer of meperidine from maternal plasma in early pregnancy. Obstet Gynecol 1978; 52:59.
467 467. Broussard CS, Rasmussen SA, Reefhuis J, et al. Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol 2011; 204:314 e1.
468 468. Klotz U. The role of pharmacogenetics in the metabolism of antiepileptic drugs: pharmacokinetic and therapeutic implications. Clin Pharmacokinet 2007; 46:271.
469 469. Jauniaux E, Gulbis B, Acharya G, et al. Maternal tobacco exposure and cotinine levels in fetal fluids in the first half of pregnancy. Obstet Gynecol 1999; 93:25.
470 470. Barr DB, Bishop A, Needham LL. Concentration of xenobiotic chemicals in the maternal–fetal unit. Reprod Toxicol 2007; 23:260.
471 471. Barr DB, Bishop A, Needham LL. Concentrations of xenobiotic chemicals in the maternal–fetal unit. Reprod Toxicol 2007; 23:260.
472 472. Ostrea EM, Jr., Matias O, Keane C, et al. Spectrum of gestational exposure to illicit drugs and other xenobiotic agents in newborn infants by meconium analysis. J Pediatr 1998; 133:513.
473 473. Bradman A, Barr DB, Claus Henn BG, et al. Measurement of pesticides and other toxicants in amniotic fluid as a potential biomarker of prenatal exposure: a validation study. Environ Health Perspect 2003; 111: 1779.
474 474. Goh YI, Chudley AE, Clarren SK, et al. Development of Canadian screening tools for fetal alcohol spectrum disorder. Can J Clin Pharmacol 2008; 15:e344.
475 475. Gray TR, Shakleya DM, Huestis MA. Quantification of nicotine, cotinine, trans‐3′‐hydroxycotinine, nornicotine and norcotinine in human meconium by liquid chromatography/tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2008; 863:107.
476 476. Ostrea EM, Morales V, Ngoumgna E, et al. Prevalence of fetal exposure to environmental toxins as determined by meconium analysis. Neurotoxicology 2002; 23:329.
477 477. Custodio PJ, Carvalho ML, Nunes F, et al. Direct analysis of human blood (mothers and newborns) by energy dispersive X‐ray fluorescence. J Trace Elem Med Biol 2005; 19:151.
478 478. Turker G, Ergen K, Karakoc Y, et al. Concentrations of toxic metals and trace elements in the meconium of newborns from an industrial city. Biol Neonate 2006; 89:244.
479 479. Schmidt D, Achermann J, Odermatt B, et al. Prenatally fabricated autologous human living heart valves based on amniotic fluid derived progenitor cells as single cell source. Circulation 2007; 116:I64.
480 480. Sessarego N, Parodi A, Podesta M, et al. Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application. Haematologica 2008; 93:339.
481 481. Pozzobon M, Piccoli M, Schiavo AA, et al. Isolation of c‐Kit+ human amniotic fluid stem cells from second trimester. Methods Mol Biol 2013; 1035:191.
482 482. Vigeh M, Yokoyama K, Ramezanzadeh F, et al. Blood manganese concentrations and intrauterine growth restriction. Reprod Toxicol 2008; 25:219.
483 483. Osada H, Watanabe Y, Nishimura Y, et al. Profile of trace element concentrations in the feto‐placental unit in relation